Form4insider filings, from the source

SEC Form 4 · accession 0001012975-18-000083

Altimmune, Inc. · ALT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jan 17, 2018
Accepted (ET)
Jan 19, 2018 · 4:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326190

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, par value $0.0001F1,F2,F3Jan 17, 2018J11,655—A157,155ISee Footnote
Common Stock, par value $0.0001F1,F2,F4Jan 17, 2018J15,541—A109,488ISee Footnote
Common Stock, par value $0.0001F1,F2,F5Jan 17, 2018J11,655—A54,428ISee Footnote
Common Stock, par value $0.0001F2,F6holding———416,043ISee Footnote
Common Stock, par value $0.0001F2,F7holding———230,103ISee Footnote
Common Stock, par value $0.0001F2,F8holding———183,690ISee Footnote
Common Stock, par value $0.0001F2,F9holding———179,359ISee Footnote
Common Stock, par value $0.0001F2,F10holding———151,441ISee Footnote
Common Stock, par value $0.0001F2,F11holding———116,654ISee Footnote
Common Stock, par value $0.0001F2,F12holding———105,804ISee Footnote
Common Stock, par value $0.0001F2,F13holding———1,774ISee Footnote
Common Stock, par value $0.0001F2,F14holding———1,255ISee Footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series B Convertible Preferred StockF1,F2,F3,F15$2.67Jan 17, 2018J23DAug 21, 2017Aug 15, 2018Common Stock, par value $0.00018,527137I
Series B Convertible Preferred StockF1,F2,F4,F15$2.67Jan 17, 2018J30DAug 21, 2017Aug 15, 2018Common Stock, par value $0.000111,369182I
Series B Convertible Preferred StockF1,F2,F5,F15$2.67Jan 17, 2018J23DAug 21, 2017Aug 15, 2018Common Stock, par value $0.00018,527137I

Explanation of responses